BTIG lowered the firm’s price target on Synchrony (SYF) to $96 from $100 and keeps a Buy rating on the shares. The firm expected Synchrony to be down after an inline to slightly worse 2026 guidance, though it is still surprised that shares are down 6% and believes the move lower is overly draconian, the analyst tells investors in a research note. This year does appear to be one of transition toward growth for Synchrony however and the expenses needed to get there, the firm added.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYF:
- Synchrony price target lowered to $93 from $101 at Barclays
- Synchrony Financial: Near-Term Investment Headwinds but Compelling 2027 Earnings Upside Support Buy Rating
- Synchrony Financial Earnings Call: Growth, Margins, and Risks
- Morning Movers: Managed care group slide after CMS notice
- Synchrony sees FY26 EPS $9.10-$9.50, consensus $9.35